YEAR 2: Review of Year 1 exploratory projects, continuation of previous teams showing promise, opportunities for new teams.
YEARS 3-4: Additional refinement of team formation and increased support to those showing promise. Improvement of technologies, move to animal testing of monitoring capabilities and biocompatibility.
YEARS 4-5: Encourage and enable technology transfer of new emerging approaches.
YEARS 5-6: Further optimization, animal testing, commence testing with human subjects, where technologies are far enough advanced, and with appropriate human protection committee approvals.
Throughout, the Directors, guided by the Scientific Steering Committee will monitor progress, bring together complementary efforts, direct funding according to progress and promise, and encourage commercialization when ready.